|
VCP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.737000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.195200E-01 |
| Normal-vs-Stage2 |
4.547600E-01 |
| Normal-vs-Stage3 |
4.345200E-01 |
| Normal-vs-Stage4 |
1.623160E-01 |
| Stage1-vs-Stage2 |
5.797400E-01 |
| Stage1-vs-Stage3 |
1.419170E-01 |
| Stage1-vs-Stage4 |
6.553700E-02 |
| Stage2-vs-Stage3 |
1.596390E-01 |
| Stage2-vs-Stage4 |
7.856100E-02 |
| Stage3-vs-Stage4 |
5.137800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.350200E-01 |
| Normal-vs-AfricanAmerican |
5.758600E-01 |
| Normal-vs-Asian |
7.411200E-01 |
| Caucasian-vs-AfricanAmerican |
6.354000E-01 |
| Caucasian-vs-Asian |
6.654400E-01 |
| AfricanAmerican-vs-Asian |
4.689000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.752000E-01 |
| Normal-vs-Female |
9.759800E-01 |
| Male-vs-Female |
9.933400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.835400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.798400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.152200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.982800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.905190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.969760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.757800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.501400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.941600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.343600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.615810E-01 |
| Classical-VS-Follicular |
1.702970E-01 |
| Classical-VS-Other |
2.141400E-01 |
| Classical-VS-Normal |
5.330200E-01 |
| Tall-VS-Follicular |
8.183400E-01 |
| Tall-VS-Other |
6.167200E-01 |
| Tall-VS-Normal |
3.407000E-01 |
| Follicular-VS-Other |
6.275400E-01 |
| Follicular-VS-Normal |
4.632400E-01 |
| Other-VS-Normal |
2.519200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.766400E-01 |
| Normal-vs-N1 |
1.282470E-02 |
| N0-vs-N1 |
9.102100E-03 |
|
|
